Live Breaking News & Updates on Caroline germa

Stay informed with the latest breaking news from Caroline germa on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Caroline germa and stay connected to the pulse of your community

Transcenta Announces Collaboration with Agilent to Develop a Claudin18.2 Companion Diagnostic to Support Osemitamab (TST001) Global Phase III Trial

Transcenta Announces Collaboration with Agilent to Develop a Claudin18.2 Companion Diagnostic to Support Osemitamab (TST001) Global Phase III Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China , Beijing , Guangzhou , Guangdong , Shanghai , Boston , Massachusetts , United-states , Suzhou , Jiangsu , Hangzhou , Zhejiang

Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics -April 03, 2024 at 08:03 am EDT

Agilent Technologies Inc. , a global leader in life sciences and diagnostics, announced today its participation in the American Association for Cancer Research Annual Meeting . At the meeting, which...

United-states , San-diego , California , London , City-of , United-kingdom , American , Marc-gunter , Bob-mcmahon , Bellal-moghis , Novocyte-opteon , Agilent-suredesign

Ikena Oncology Reports Fourth Quarter and Full Year 2023 Financial Results

12.03.2024 - IK-930 continues to advance in the clinic now with an optimized formulation with improved pharmacokinetics IK-930 clinical update planned for 2H 2024 including additional data from EHE patients in dose escalation and initial mesothelioma patient ...

Boston , Massachusetts , United-states , Mark-manfredi , Luke-shiplo , Rebecca-cohen , Nasdaq , Linkedin , Exchange-commission , Drug-administration , Lifesci-communications , Ikena-oncology-inc

AbbVie names CEO successor—Chutes & Ladders

AbbVie names CEO successor—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Chicago , Illinois , United-states , California , Paul-hudson , Marlena-fejzo , America-ph , Robert-michael , Gabrielle-masson , Rick-gonzalez , Albert-bourla , Vivek-sharma

Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer

Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France , Boston , Massachusetts , United-states , Paris , France-general- , Rebecca-cohen , Mark-manfredi , Luke-shiplo , Caroline-germa , Sergio-santillana , Paris-diderot-university

Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer

Caroline Germa, M.D., an accomplished senior executive and medical oncologist, brings over 25 years of pharmaceutical and drug development expertise

France , Boston , Massachusetts , United-states , Paris , France-general- , Sergio-santillana , Caroline-germa , Mark-manfredi , Luke-shiplo , Rebecca-cohen , University-of-lille

Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer

Ikena Oncology Appoints Caroline Germa, M.D. as Chief Medical Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France , Paris , France-general- , Boston , Massachusetts , United-states , Luke-shiplo , Mark-manfredi , Sergio-santillana , Rebecca-cohen , Caroline-germa , Paris-diderot-university

Transcenta Unveils Updated Efficacy Data from Osemitamab (TST001) Plus CAPOX as First-Line Treatment for G/GEJ Cancer Study at ESMO 2023

Latest data reveals a 55% confirmed response rate, median duration of response (DoR) and median progression-free survival (PFS) of more than 12 months for all

China , Shanghai , Hangzhou , Zhejiang , Suzhou , Jiangsu , Princeton , Massachusetts , United-states , Beijing , Guangzhou , Guangdong

FDA Grants Transcenta Clearance to Proceed with Global Phase III Trial of Osemitamab (TST001) as First-Line Treatment for Gastric/Gastroesophageal Cancer Patients

/PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in...

South-korea , China , Suzhou , Jiangsu , Princeton , Massachusetts , United-states , Shanghai , Hangzhou , Zhejiang , Boston , Guangzhou

Transcenta Received Approvals from China CDE and South Korea MFDS to Initiate TranStar 301 Global Phase III Pivotal Trial of Osemitamab (TST001)

/PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in...

South-korea , China , Beijing , Shanghai , Hangzhou , Zhejiang , Princeton , Massachusetts , United-states , Guangzhou , Guangdong , Boston